Endometriosis-associated Malignancy

N. Krawczyk, M. Banys-Paluchowski, D. Schmidt, U. Ulrich, T. Fehm

39 Citations (Scopus)

Abstract

Endometriosis is a common condition in women of reproductive age. According to several epidemiological studies endometriosis may be associated with increased risk of various malignancies. However, endometriosis-associated malignancy (EAM) is defined by certain histological criteria. About 80% of EAM have been found in the ovary, whereas 20% are localized in extragonadal sites like intestine, rectovaginal septum, abdominal wall, pleura and others. Some authors suggest that EAM arise from atypical endometriosis as an intermediate lesion between endometriosis and cancer. Moreover, a number of genetic alterations, like loss of heterozygosity (LOH), PTEN, ARID1A and p53 mutations have been found in both endometriosis and EAM. Endometriosis-associated ovarian cancer (EAOC) is mostly a well or intermediately differentiated tumor of endometrioid or clear cell histological sub-type. Women affected by EAOC are on average five to ten years younger than non-EAOC patients; in most of the cases EAOC is a low stage disease with favorable clinical outcome. Since EAM is a rare condition systematic data on EAM are still missing. A systematic retrospective study on endometriosis-associated malignancies (EAM study) is currently being conducted by the Endometriosis Research Foundation together with the study groups on ovarian and uterine tumors of the working group for gynecological oncology (AGO) (gyn@mlk-Berlin.de).

Original languageEnglish
JournalGeburtshilfe und Frauenheilkunde
Volume76
Issue number2
Pages (from-to)176-181
Number of pages6
ISSN0016-5751
DOIs
Publication statusPublished - 01.02.2016

Fingerprint

Dive into the research topics of 'Endometriosis-associated Malignancy'. Together they form a unique fingerprint.

Cite this